Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

OCULAR THERAPEUTIX, INC (OCUL) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/08/2019 GN New Research: Key Drivers of Growth for The Chemours, Superior Industries International, Caleres, G1 THERAPEUTICS, Vitamin Shoppe, and Ocular Therapeutix — Factors of Influence, Major Initiatives and Sustained Production
10/18/2018 GN Investor Expectations to Drive Momentum within Teradata, Liberty TripAdvisor, CPI Card Group, Cara Therapeutics, Ocular Therapeutix, and G-III Apparel Group, LTD — Discovering Underlying Factors of Influence
08/27/2018 GN Factors of Influence in 2018, Key Indicators and Opportunity within Lindblad Expeditions, Milacron, Lantheus, RCI Hospitality, Ingles Markets, and Ocular Therapeutix — New Research Emphasizes Economic Growth
05/03/2018 GN Investor Expectations to Drive Momentum within Quaker Chemical, Ocular Therapeutix, Viad, Ingredion, LivePerson, and Tableau Software — Discovering Underlying Factors of Influence
03/09/2018 GN Report: Exploring Fundamental Drivers Behind Cenovus Energy, Depomed, Zoe's Kitchen, NetApp, Keryx Biopharmaceuticals, and Ocular Therapeutix — New Horizons, Emerging Trends, and Upcoming Developments
01/08/2018 GN New Research Coverage Highlights TTM Technologies, LogMeIn, Ocular Therapeutix, Everbridge, Power Integrations, and CBIZ — Consolidated Revenues, Company Growth, and Expectations for 2018
08/31/2017 GN 5-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm
08/31/2017 GN DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ocular Therapeutix, Inc. (Nasdaq:OCUL) To Contact The Firm
08/28/2017 GN DEADLINE REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm
08/22/2017 GN OCUL Investors Deadline Reminder: Hagens Berman Reminds Investors in Ocular Therapeutix, Inc. of the September 5, 2017 Lead Plaintiff Deadline in the Pending Securities Class Action
08/17/2017 GN The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Ocular Therapeutix, Inc. Shareholders and a Lead Plaintiff Deadline of September 5, 2017 (OCUL)
08/16/2017 GN OCUL INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ocular Therapeutix, Inc. and a Lead Plaintiff Deadline of September 5, 2017
08/15/2017 GN INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Class Action Complaint on Behalf of Ocular Therapeutix, Inc. Shareholders and Lead Plaintiff Deadline is Set for September 5, 2017 – OCUL
08/11/2017 GN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline – OCUL
08/10/2017 GN EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL
08/02/2017 GN The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Ocular Therapeutix, Inc. Shareholders and a Lead Plaintiff Deadline of September 5, 2017 (OCUL)
07/31/2017 GN IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Reminds Investors with Losses to Contact the Firm
07/31/2017 GN OCUL EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Ocular Therapeutix, Inc. and a Lead Plaintiff Deadline of September 5, 2017
07/27/2017 GN IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Reminds Investors with Losses to Contact the Firm
07/27/2017 GN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocular Therapeutix, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 5, 2017 – OCUL
07/27/2017 GN SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ocular Therapeutix, Inc. (OCUL) & Lead Plaintiff Deadline: September 5, 2017
07/13/2017 GN IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm
07/13/2017 GN SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ocular Therapeutix, Inc. (OCUL) & Lead Plaintiff Deadline: September 5, 2017
07/12/2017 GN SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Ocular Therapeutix, Inc. and Certain Officers – OCUL
07/12/2017 GN IMPORTANT OCULAR THERAPEUTIX, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Ocular Therapeutix, Inc.
07/12/2017 GN OCULAR THERAPEUTIX ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ocular Therapeutix, Inc. To Contact The Firm
07/11/2017 GN SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ocular Therapeutix, Inc. (Nasdaq:OCUL) To Contact Brower Piven Before The Lead Plaintiff Deadline
07/11/2017 GN Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ocular Therapeutix, Inc.
07/10/2017 GN Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ocular Therapeutix, Inc. (OCUL)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy